Top individual investors see mixed fortunes in the December quarter


India’s top individual investors saw mixed fortunes in the December quarter, with some portfolios making gains, while others witnessed a decline in value as the stock market was on a roller coaster trading high during the period. Listed properties of investors, including those of Ashish Dhawan, Hemendra Kothari, Vijay Kedia, Madhusudan Keela, and Akash Bhansali, fell between 3% and 19% during the period. In contrast, Nimesh Shah, Ashish Kachulia, Mukul Aggarwal, Anil Kumar Goyal, and the family of the late Rakesh Jhunjwala gained between 2% and 11%, according to a study based on data from primeinfobase.com.

Benchmark indices move in different directions during the quarter. The Nifty and Nifty Midcap 150 index rose around 6% between October and December, while the Nifty Smallcap 250 index declined 0.05% during the same period.

Portfolio values ​​are calculated for stocks where these investors own more than 1% equity in companies during the quarter. Nimish Shah’s portfolio grew by 10.1% in the December quarter.

Screenshot 2026-03-09 062323Institutions

He increased his holdings in LMW, Asahi India Glass, and Vascon Engineers, while reducing stakes in Elgi Equipment, Banari Amman Sugars, and Zodiac Clotting Company.
Ashish Kachulia and Mukul Aggarwal’s holdings gained 7.6% and 5.7% respectively. Kachulia raised his stake in 10 stocks, including Shelly Engineering Plastics, Knowledge Marine & Engineering Works, Google Prepaid, Beta Medicines, and Carisel.


Agarwal increased its holdings in 23 stocks and decreased exposure in 36 during the quarter. Newland Laboratories, Radico Khaitan, and Zota Healthcare were the top holdings in his portfolio. Titan, Inventurus Knowledge, and Metro Brands were the top listed securities in late Rakesh Jhunjhunwala’s portfolio.
His family’s holdings grew 2.4% in the quarter. The Jonjunwala family reduced exposure to 16 stocks, including Metro Brands, Concorde Biotech, Fortis Healthcare, Tata Motors PV, Cresyl, NCC, Jubilant Pharma, and Indian Hotels. Among the decliners, Ashish Dhawan’s portfolio fell 19.1%, while Hemendra Kothari’s fell nearly 14% in the December quarter.

Add Comment